Atomo Diagnostics Limited products

A fast, accurate point of care COVID-19 antigen test for the qualitative detection of nucleocapsid protein antigens specific to the SARS-CoV-2 virus. Utilising an anterior nasal swab specimen obtained from individuals suspected of having COVID-19, the Atomo COVID-19 Antigen Test is easy to use, giving a result in as little as 10 minutes.

The only HIV Self Test listed on the Australian Register of Therapeutic Goods 311989.

Ideally suited for point of care testing, Atomo HIV tests for professional use need only 10uL of capillary blood, and gives an accurate result in just 15 minutes.

NG Biotech partnered with Atomo to bring its pregnancy rapid diagnostic test to market.

Lumos Diagnostics partnered with Atomo to develop a novel, rapid, point-of-care test that differentiates between viral versus bacterial acute respiratory infection in 10 minutes.

The Elion platform has been especially designed for self test users and makes rapid testing easier than ever before, with easy blood collection and interlocked user steps that mitigate common user errors.

The Galileo RDT platform improves test performance and usability with an integrated safety lancet, unique blood collection and delivery system in an easy to use all-in-one device that can be deployed in home or clinical settings.

The Pascal platform delivers improved performance and usability in self test and point of care settings with a built-in safety lancet, unique blood collection system and integrated buffer delivery mechanism.

The AtomoRapid Franklin RDT platform offers all-in-one convenience with a built-in safety lancet, innovative blood collection feature, integrated blood and buffer delivery system, and digital LCD result reader.